PedAM
Pediatric Disease Annotations & Medicines
| Disease | thromboembolism |
| Phenotype | C0684249|lung carcinoma |
| Sentences | 2 |
| PubMedID- 21165299 | Risk factors associated with arterial thromboembolism in patients with lung carcinoma are chemotherapy (especially cisplatin based) [15], targeted therapy (bevacizumab) [16], tumor induced nonbacterial thrombotic endocarditis [17] and disseminated intravascular coagulation [18]. |
| PubMedID- 24348827 | By developing a middle- to old-aged c57 mouse model of lewis lung carcinoma (llc) with concurrent thromboembolism, we investigated the effect of hsos treatment on the hypercoagulable state, assessed its role in preventing tumor metastasis through promoting blood circulation and removing blood stasis, and explored the possible mechanisms involved. |
Page: 1